cytosine has been researched along with Epidermodysplasia Verruciformis in 3 studies
Epidermodysplasia Verruciformis: An autosomal recessive trait with impaired cell-mediated immunity. About 15 human papillomaviruses are implicated in associated infection, four of which lead to skin neoplasms. The disease begins in childhood with red papules and later spreads over the body as gray or yellow scales.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Darwich, E | 1 |
| Darwich, L | 1 |
| Cañadas, MP | 1 |
| Klaustermeier, J | 1 |
| Ercilla, G | 1 |
| Alsina-Gibert, M | 1 |
| Mascaró, JM | 1 |
| Potthoff, A | 1 |
| Wieland, U | 1 |
| Kreuter, A | 1 |
| Preiser, W | 1 |
| Kapur, N | 1 |
| Snoeck, R | 1 |
| Groves, RW | 1 |
| Brink, NS | 1 |
3 other studies available for cytosine and Epidermodysplasia Verruciformis
| Article | Year |
|---|---|
New human papillomavirus (HPV) types involved in epidermodysplasia verruciformis (EV) in 3 HIV-infected patients: response to topical cidofovir.
Topics: Administration, Topical; Adult; AIDS-Related Opportunistic Infections; Antiviral Agents; Cidofovir; | 2011 |
Failure of intravenous cidofovir for generalized verrucosis in a patient with severe combined immunodeficiency.
Topics: Antiviral Agents; Cidofovir; Cytosine; Epidermodysplasia Verruciformis; Follow-Up Studies; Humans; M | 2012 |
No apparent effect of cidofovir in epidermodysplasia verruciformis.
Topics: Adult; Antiviral Agents; Cidofovir; Cytosine; Epidermodysplasia Verruciformis; Humans; Male; Organop | 2000 |